Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Sanofi (SNYNF) over the last 5 years, with Q4 2025 value amounting to -$54.7 million.

  • Sanofi's Exchange Rate Effect fell 29386.73% to -$54.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$163.8 million, marking a year-over-year decrease of 16260.72%. This contributed to the annual value of -$53.1 million for FY2025, which is 27749.33% down from last year.
  • Latest data reveals that Sanofi reported Exchange Rate Effect of -$54.7 million as of Q4 2025, which was down 29386.73% from -$63.1 million recorded in Q3 2025.
  • Sanofi's 5-year Exchange Rate Effect high stood at -$5.4 million for Q1 2024, and its period low was -$63.1 million during Q3 2025.
  • For the 3-year period, Sanofi's Exchange Rate Effect averaged around -$28.3 million, with its median value being -$23.0 million (2025).
  • In the last 5 years, Sanofi's Exchange Rate Effect soared by 5965.23% in 2024 and then tumbled by 29386.73% in 2025.
  • Over the past 3 years, Sanofi's Exchange Rate Effect (Quarter) stood at -$34.4 million in 2023, then skyrocketed by 59.65% to -$13.9 million in 2024, then plummeted by 293.87% to -$54.7 million in 2025.
  • Its Exchange Rate Effect stands at -$54.7 million for Q4 2025, versus -$63.1 million for Q3 2025 and -$24.9 million for Q2 2025.